Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | CPA3 | P15088 | 3/20 | 0.48 |
| ▸ | CPA1 | P15085 | 2/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.48 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1573822 | 1.00 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL296747 | 1.00 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL2238484 | 0.88 | MME (0.48) | CYP1A2CPA1FOLH1NPSR1 | |
| SCHEMBL2238482 | 0.88 | MME (0.48) | CYP1A2CPA1FOLH1NPSR1 | |
| SCHEMBL607090 | 0.85 | SLC7A5 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL607091 | 0.85 | SLC7A5 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL11710892 | 0.82 | ADAMTS5 (0.50) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL31114841 | 0.82 | ADAMTS5 (0.50) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL2466759 | 0.82 | CYP1A2 (0.57) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL157789 | 0.82 | CYP1A2 (0.57) | CYP1A2ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9993516-B2 | Treatment of left ventricular non-compaction and dilated cardiomyopathy by inhibiting melanocortin receptor four | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2018-06-12 | — | — | US | claimed |
| US-20160296587-A1 | THERAPIES FOR LEFT VENTRICULAR NON-COMPACTION AND DILATED CARDIOMYOPATHY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2016-10-13 | — | — | US | claimed |
| WO-2015077334-A2 | THERAPIES FOR LEFT VENTRICULAR NON-COMPACTION AND DILATED CARDIOMYOPATHY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2015-05-28 | — | — | WO | claimed |
| EP-0063423-B1 | GNRH ANTAGONISTS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1985-08-14 | — | — | EP | claimed |
| EP-0038135-B1 | LRF ANTAGONISTS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1984-07-11 | — | — | EP | claimed |
| US-4409208-A | PEPTIDES WHICH INHIBIT GONADOTROPINS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1983-10-11 | — | — | US | claimed |
| US-4386074-A | DECAPEPTIDE ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1983-05-31 | — | — | US | claimed |
| EP-0063423-A1 | GnRH antagonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1982-10-27 | — | — | EP | claimed |
| EP-0047079-A1 | Nonapeptides affecting gonadal function | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1982-03-10 | — | — | EP | claimed |
| EP-0038135-A2 | LRF antagonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1981-10-21 | — | — | EP | claimed |
| US-9993516-B2 | Treatment of left ventricular non-compaction and dilated cardiomyopathy by inhibiting melanocortin receptor four | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| EP-3125906-A1 | PEPTIDE FRAGMENTS OF NETRIN-1 AND COMPOSITIONS AND METHODS THEREOF | The Regents of the University of California (US) | 2017-02-08 | — | — | EP | disclosed |
| US-20160296587-A1 | THERAPIES FOR LEFT VENTRICULAR NON-COMPACTION AND DILATED CARDIOMYOPATHY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2016-10-13 | — | — | US | disclosed |
| WO-2015153402-A1 | PEPTIDE FRAGMENTS OF NETRIN-1 AND COMPOSITIONS AND METHODS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-10-08 | — | — | WO | disclosed |
| WO-2015077334-A2 | THERAPIES FOR LEFT VENTRICULAR NON-COMPACTION AND DILATED CARDIOMYOPATHY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| EP-0063423-A1 | GnRH antagonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1982-10-27 | — | — | EP | disclosed |
| EP-0047079-A1 | Nonapeptides affecting gonadal function | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1982-03-10 | — | — | EP | disclosed |
| EP-0047079-A1 | Nonapeptides affecting gonadal function | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1982-03-10 | — | — | EP | disclosed |
| EP-0038135-A2 | LRF antagonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1981-10-21 | — | — | EP | disclosed |
| EP-0038135-A2 | LRF antagonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1981-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160296587-A1 | THERAPIES FOR LEFT VENTRICULAR NON-COMPACTION AND DILATED CARDIOMYOPATHY | TNNI3, TNNT2, TNNC1 | CYP1A2 4865/4885ALPI 4612/4885PKM 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.